Seeing Is Believing
Currently out of the existing stock ratings of Colleen Kusy, 61 are a BUY (85.92%), 10 are a HOLD (14.08%).
Analyst Colleen Kusy, currently employed at BAIRD, carries an average stock price target met ratio of 52% that have a potential upside of 39.57% achieved within 153 days.
Colleen Kusy’s has documented 137 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 27-Jul-2026.
Analyst best performing recommendations are on NUVL (NUVALENT).
The best stock recommendation documented was for NUVL (NUVALENT) at 9/10/2024. The price target of $105 was fulfilled within 6 days with a profit of $17.51 (20.01%) receiving and performance score of 33.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Jun-2023
$39
$28.86 (284.62%)
$26
Buy Since 19-Mar-2024
$38
$26 (216.67%)
$41
3 months 19 days ago
(02-Jun-2026)
0/4 (0%)
$25.71 (209.19%)
Buy Since 27-Aug-2025
$46
$34 (283.33%)
$40
4 months 9 days ago
(12-May-2026)
0/4 (0%)
$15.59 (51.27%)
Buy Since 05-Oct-2023
$50
$38 (316.67%)
$40
6 months 16 days ago
(05-Mar-2026)
0/7 (0%)
$22.26 (80.25%)
Buy Since 14-Jun-2023
$29
$17 (141.67%)
$30
10 months 8 days ago
(13-Nov-2025)
6/6 (100%)
$9.71 (50.34%)
474
Which stock is Colleen Kusy most bullish on?
Which stock is Colleen Kusy most reserved on?
What Year was the first public recommendation made by Colleen Kusy?